June 1 (Reuters) - Immutep Ltd (IMM) :
- IMMUTEP ENTERS INTO A NEW COLLABORATION WITH MERCK KGAA, DARMSTADT, GERMANY FOR LAG-3 THERAPY, EFTI
- IMMUTEP LTD - FIRST PATIENT IS EXPECTED TO BE ENROLLED AND DOSED IN H2 OF CALENDAR YEAR 2021
News: IMM Immutep Enters Into A New Collaboration With Merck KGaA, Darmstadt, Germany For Lag-3...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.3¢ |
Change
0.008(2.54%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 29.5¢ | $354.7K | 1.191M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 148607 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 196017 | 17 |
View Market Depth
| Last trade - 12.59pm 09/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |